1. World Health Organisation. World Malaria Report. 2016.
2. European Medicines Agency. Assessment report MosquirixTM International non-proprietary name: Plasmodium falciparum and hepatitis B vaccine (recombinant, adjuvanted) Procedure No. EMEA/H/W/002300/0000 [Internet]. London:United Kingdom; 2015 [cited 2017 Aug 21]. Available from: Available at www.ema.europa.eu/docs/en_GB/document_library/Other/2015/10/WC500194577.pdf
3. Clinical Trials Partnership. Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites;S The RTS;PLOS Med,2014
4. Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children;A Olotu;N Engl J Med,2016
5. World Health Organisation. Update on RTS,S Malaria Vaccine Implementation Programme. Geneva, Switzerland. 2017.